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Abstract.  
A decrease in Reactive Oxygen Species (ROS) 
production has been associated with extended 
lifespan in animal models of longevity.  Mice 
deficient in the p66Shc gene are long-lived, and 
their cells are both resistant to oxidative stress and 
produce less ROS. Our microarray analysis of 
p66Shc(-/-) mouse tissues showed alterations in 
transcripts involved in heme and superoxide 
production and insulin signaling. Thus we carried 
out analysis of ROS production by NADPH 
Oxidase (PHOX) in macrophages of control and 
p66Shc-knockout mice. p66Shc(-/-) mice had a 
40% reduction in PHOX-dependent superoxide 
production. To confirm whether the defect in 
superoxide production was a direct consequence of 
p66Shc deficiency, p66Shc was knocked down with 
siRNA in the macrophage cell line RAW264, and a 
30% defect in superoxide generation was observed. 
The pathway of PHOX-dependent superoxide 
generation was investigated.  PHOX protein levels 
were not decreased in mutant macrophages, 
however the rate and extent of phosphorylation of 
p47phox was decreased in mutants, as was 
membrane translocation of the complex. 
Consistently phosphorylation of protein kinase C 
delta, Akt and ERK (the kinases responsible for 
phosphorylation of p47phox) was decreased.  
Thus, p66Shc deficiency causes a defect in 
activation of the PHOX complex that results in 
decreased superoxide production. p66Shc-deficient 
mice have recently been observed to be resistant to 
atherosclerosis, and oxidant injury in kidney and 
brain.  Since phagocyte-derived superoxide is often 
a component of oxidant injury and inflammation, 
we suggest that the decreased superoxide 
production by PHOX in p66Shc-deficient mice 
could contribute significantly to their relative 
protection from oxidant injury, and consequent 
longevity.  
 
Introduction  
The free radical theory of aging predicts that Oxygen-
derived free radicals produced throughout life causes 
progressive damage and inflammation ultimately 
leading to death [1].  In the long-lived p66Shc-
deficient mouse, embryonic fibroblasts produce less 
ROS and are more resistant to stressors including 
hydrogen peroxide, and signal less through ROS-
dependent pathways [2, 3]. p66Shc-deficient mice 
produce less mitochondrial ROS following CCl4 
stimulation [4]. p66ShcKO mice also have reduced 
systemic and tissue oxidative stress [5], and are 
resistant to atherosclerosis [6], oxidant-related 
endothelial dysfunction [7], kidney oxidant injury [8], 
and are protected from high fat diet induced obesity 
[3]. 
We carried out a microarray study that indicated 
alterations in transcripts related to heme and NADPH 
Oxidase superoxide production, and so investigated 
the impact of the p66Shc-deficiency on ROS 
generating activity of macrophages.  
 
Experimental procedures 
 
Animals p66Shc(-/-) mice have being described 
previously [2]. Mice were kept pathogen-free through 
the study on barrier facility at UC Davis. All 
experimental procedures were approved by the 
Institutional Animal Care and Use Committee 
(IACUC) and were performed in compliance with 
local, state, and federal regulations. Mice, used for 
this study were 2-6 month old and were age matched 
for each experiment. 
 
Antibodies and reagents Diphenyleneiodonium (DPI) 
and Gliotoxin was purchased from Axxora LLC (San 
Diego, CA), Phorbol 12-myristate 13-acetate (PMA) 
was from Enzo Life Sciences International INC. 
(Plymouth Meeting, PA), N-formil-Met-Leu-Phe 
(fMLP) was from Tocris Bioscience (Ellisville, MO), 
arachidonic acid (AA) was from Acros Organics 
(Morris Plains, NJ), OxyBURST Green H2HFF-BSA 
dye was purchased from Molecular Probes (Eugene, 
Oregon), goat anti-p22Phox antibody was from Santa 
Cruz Biotechnology INC. (Santa Cruz, CA), rabbit 
anti-p40Phox polyclonal and rabbit anti-p67Phox 
polyclonal antibodies were from Upstate Cell 
Signaling Solutions (Lake Placid, NY), rabbit anti-
phospho p40Phox polyclonal antibody were from Cell 
Signaling Technology INC. (Danvers, MA), goat anti-
p47Phox polyclonal, goat anti-Rac2 polyclonal, rabbit 
anti-PKC delta polyclonal and rabbit anti-phospho-
PKC delta monoclonal antibody was from Abcam 
INC. (Cambrige, MA), rabbit anti-Shc polyclonal 
antibodies and mouse anti-gp91Phox antibody was 
from BD Biosciences (San Diego, CA),  Rac/cdc42 
Assay reagent PAK-1 PBD agarose conjugate and 
mouse monoclonal anti-Rac1 antibody were from 
Millipore INC. (Temecula, CA),  goat anti – rabbit 
monoclonal antibody labeled with IR-dye 700CW, 
donkey anti-mouse monoclonal antibody labeled with 
IR-dye 800CW and donkey anti-goat polyclonal 
antibodies, conjugated with IR-dye 800CW were from 
Li-Cor Biosciences (Lincoln, NE). Primers for 
quantification of p66Shc forward 5’-
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gaaagttggggcggtgac-3’ and reverse 5’-
gacccattctgcctcctc-3’, actin beta forward 5’-
tggaacggtgaaggcgacagcagttg-3’ and reverse 5’-
gtggcttttgggagggtgagggactt-3’, p66Shc specific 
siRNA [9] were synthesized on Integrated DNA 
Technology (Coralville, IA), non-target control 
siRNA-AllStar was purchased from Qiagen 
(Valencia, CA). RAW264.7-cells were from ATCC 
(Manassas, VA), Bio-Lyte 5/8 and Bio-Lyte 3/10 
Ampholytes were from Bio-Rad laboratories 
(Hercules, CA). 
 
Peritoneal macrophages-- (PM) were harvested 4 
days after thioglycollate injection of the peritoneal 
cavity.  Cells were washed with chilled PBS, red 
blood cells were hypotonically lysed and 
macrophages were resuspended in RPMI 1640 
containing 15% FBS, 50 µg/ml penicillin and 50 
µg/ml streptomycin and plated on 100 mm round Petri 
- dishes. After 2 hours incubation at 37°C, 5% CO2 
non-adherent cells were removed and the remaining 
adherent cells were cultured in RPMI 1640 containing 
15% FBS, 50 µg/ml penicillin, and 50 µg/ml 
streptomycin for no more than 48 hours before 
functional assays. 
 
Tissue culture—RAW264.7 cells were cultured in 
RPMI 1640 containing 15% FBS, 50 µg/ml penicillin 
and 50 µg/ml streptomycin, and sub-cultured twice a 
week. 
 
RNA isolation and Semi-quantitative RTPCR – Total 
RNA was extracted by direct lysis of the cells on the 
tissue culture plate using RNeasy Mini Kit (Qiagen) 
according to manufacturer’s instructions. Equal RNA 
amounts were added to Superscript II First Strand 
reverse transcriptase reaction mixture (Invitrogen) 
with oligo(dT) primer. The resulting templates were 
subject to Syber Green-based quantitative PCR using 
specific primers, listed above. The cycling conditions 
were 94◦C 3 minutes as initial denaturation followed 
by 35 cycles of 94◦C 15 second, 60◦C 20 second and 
72◦C 15 second and finished by melting curve by 
gradual heating until 95◦C. Only experiments with a 
single melting peak were considered for analysis. 
Reaction qualities have being verified by gel 
electrophoresis. PCR was carried out using 
LightCycler480 Real time PCR instrument and 
LightCycler480 analysis software (Roshe). 
 
Blood heme measurement was performed on heart 
blood samples. Blood was collected in capillary tubes 
containing electrolyte-balanced heparin at 70 IU/ml of 
blood.  Following collection, blood samples were 
immediately analyzed for hemoglobin levels on 
Radiometer OSM3 Hemoximeter (Copenhagen, 
Denmark). 
 
Superoxide production by RAW264.7 cells – Cells 
were cultivated and transfected on 6 well plates 
(Nunc) started at two hundred thousand cells per well. 
Transfection was performed as described, and after 48 
hours cells were washed with PBS pH 7.4 at 37◦C, 
and 3 ml of KRP, which contains PBS pH 7.4, 1 mM 
CaCl2, 1.5 mM MgCl2, 5.5 mM glucose and 10 µg/ml 
OxyBURST H2HFF Green BSA dye was added. Cells 
were incubated at 37◦C in the dark for two minutes 
and readings of fluorescence at 530 nm exited at 480 
nm were taken during 12 minutes using CytoFluor 
Multi-Well Plate Reader (PerSeptive Biosystems), 
then PMA until 3 µg/ml was added to experimental 
wells and readings were continued during next 30 
minutes, DMSO (solvent for PMA) was added to 
control cells, used as baseline. After the assay, one 
half of the cells from each well were taken to the cell 
count and trypan blue based viability assay, and the 
number of cells in each well was calculated. 
Fluorescence readings were normalized to exact 
viable cell number in each well. Another half of the 
cells were used for either: protein extraction for 
Western Blots, or total RNA extraction for Semi-
quantitative Reverse Transcriptase-PCR.  
For the Gliotoxin or DPI inhibition of NAD(P)H-
oxidase, Gliotoxin or DPI were directly added to the 
tissue culture media until final concentration of 10 
µg/ml for Gliotoxin or 10 µM for DPI, and cells were 
pre-incubated during 10 minutes at 37◦C prior to 
measurements of superoxide production.  
 
Superoxide production by Mouse Peritoneal 
Macrophages (PM) – For the H2HFF-based assay 
cells were cultivated at 37◦C and 5% CO2 on 100 mm 
tissue culture dishes for 24-48 hours after harvesting. 
Media was RPMI 1640 containing 15% FBS, 50 
µg/ml penicillin, 50 µg/ml streptomycin. Cells were 
washed with ice-cold PBS pH7.4 and resuspended in 
ice-cold KRP. Aliquots were taken for cell counting 
and viability assay, exact number of cells was 
calculated. Indicated number of cells was taken into 
warm 96 well plate with fresh KRP supplemented 
with OxyBURST H2HFF Green BSA dye until 10 
µg/ml, final volume was 190 µl. After two minutes 
incubation in the dark readings were started at 
emission 530 nm and excitation of 480 nm. Stimulus: 
PMA until 3 µg/ml, fMLP until 3 µM or AA until 15 
µM were added at minute 12, and readings were 
continued during next 30 minutes. Ten seconds 
mixing step was used in each reading cycle of the 
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instrument to prevent the cells from sedimentation. 
Gliotoxin or DPI inhibition was done similarly as 
described above. 
For SOD-inhibitable cytochrome c reduction based 
assay PM were harvested from peritoneal cavity 4 
days after thioglycollate injection by lavage with ice-
cold PBS. Contaminating erythrocytes were 
hypotonically lysed and PM were resuspended in 
KRP, pH 7.4 at 5X106 cells per ml and kept on ice 
until use. The reaction mixture was 250 µl and 
contained 50 µM cytochrome c and 6.25X105 PM in 
KRP. The superoxide release was induced with 4 µg 
of PMA and readings of absorbance at 550 nm were 
taken during 10 minutes using Tecan Spectra 
Rainbow 96 well plate spectrophotometer (Tecan, 
Austria). The same assay was carried out in the 
presence of SOD at 2.5 µg per reaction in order to 
evaluate the superoxide independent change in 
absorbance. A sample without PMA was used as a 
negative control. 
 
siRNA transfection of RAW264.7 cells was carried 
out on 6 well plates (Nunc). Two hundred thousand 
cells per well were plated in antibiotic free RPMI 
1640 15% FBS and after settlement washed with PBS. 
Transfection mixture was prepared using 70 nM 
siRNA specific for p66Shc or non-specific AllStar 
siRNA (Qiagen), OPTIMEM media (Invitrogen) and 
Lipofectamine 2000 (Invitrogen) according to 
manufacturer protocol. After six hours of transfection 
in 600 µl of transfection mixture per well, cells were 
feed with fresh RPMI 1640 supplemented with 15% 
FBS. After 48 hours of cultivation cells were used in 
NAD(P)H-oxidase measurement assays followed by 
cell counting and RNA or protein extraction as 
described above.  
 
Microarray analysis of differently regulated 
transcripts – Total RNA was extracted from 
following tissues of individual age matched mouse: 
liver, spleen, lungs, epididymal fat, PM, at 3 month of 
age and liver, retroperitoneal fat, and spleen at 12 
month of age, using TRIzol reagent according to the 
manufacturer instructions (Invitrogen), then purified 
using RNeasy Mini Kit (Qiagen). Two mutant and 
two control mice were used for each experiment. 
Totally 16 samples from mutant mice and 16 samples 
from control mice tissues were used. First and second 
strand of cDNA were generated using One-Cycle 
cDNA Synthesis Kit (Affymetrix), labeled cRNA’s 
were synthesized using Gene Chip IVT Labeling 
System (Affymetrix), fragmented and hybridized to 
the Mouse Genome 430 2.0 Arrays (Affymetrix) 
according to manufacturer instructions. Resulted CEL 
files were analyzed for each group of tissue 
individually using dChip (DNA chip analyzer) 
software [10]. Updated annotations were obtained 
from the NetAffx database and multi-sample analysis 
performed by combining the dChip lists using Excel. 
Probsets with a pCall >20% and p < 0.05 were 
considered significantly altered. 
An additional set of CEL files was obtained from the 
Pelicci group. Liver, spleen and lungs samples from 3 
month old p66Shc(-/-) and 3 month old control mice 
were hybridized in a similar way to the Affymetrix 
Mouse Genome U74Av2 chips. RNA samples of each 
tissue from three animals were pulled together. Two 
chips for each RNA sample of control and two chips 
for each RNA sample of mutant mice were used. The 
CEL files were analyzed with dChip in our laboratory 
and incorporated into our expression data table using 
>90% probsets match between two different chips 
formats Mouse Genome 430 2.0 and U74Av2. 
Probesets were then resorted by number of times to be 
significantly changed through different experiments. 
Lists of top 250 up- and 250 down-regulated genes 
were categorized using Onto-Express Pathway 
analysis tool and lists of 100 top up- and 100 top 
down-regulated genes were categorized using Onto-
Express Bioprocess analysis tool [11]. For filtering 
OntoExpress results we used cutoff for p-value 0.05. 
Lists of significantly altered pathways counting 27 
and significantly altered bioprocesses – 18 were 
sorted by impact factor and p-value respectively, and 
fore top up- and fore top down-regulated were 
tabulated. 
 
Western Blotting – Total protein was isolated by 
direct lysis of adherent cells or from cell pellets 
washed with ice-cold PBS pH7.4 using Cell Lysis 
buffer (Cell Signaling Technologies), containing 20 
mM Tris-HCl (pH 7.5) 150 mM NaCl, 1 mM 
Na2EDTA, 1 mM EGTA, 1% Triton, 2.5 mM sodium 
pyrophosphate, 1mM β-glycerophosphate, 1 mM 
Na3VO4, 1 µg/ml leupeptin, 1mM 
Phenylmethanesulfonyl fluoride and supplemented 
with Complete Mini Protease Inhibitor Cocktail and 
PhosStop Phosphatase Inhibitor Cocktail (Roshe). 
Forty microgram of protein per line, as determined by 
Bradford assay (BioRad Laboratories), were resolved 
by SDS-PAGE, transferred to nitrocellulose 
membrane, blocked with Odyssey Blocking Buffer 
(Li-Cor Biosciences) and hybridized with indicated 
primary antibodies followed by development with 
infrared IR-dye 700CW and/or 800CW labeled 
secondary antibodies (Li-Cor). Blots were scanned on 
Licor Odyssey infrared imaging instrument and 
quantified using Odyssey 2.1 software. Use of 
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different IR-dyes labeled secondary antibodies 
allowed to measure level of housekeeping proteins at 
the same time as the proteins of interest on the same 
membrane and improves accuracy of quantification 
and normalization.  
 
Two dimensional electrophoresis – Macrophages 
were induced with DMSO (Mock treatment) or PMA 
for 5 minutes, as indicated, reactions were stopped 
with 5 volumes of ice-cold PBS; cells were collected 
by quick centrifugation at 0◦C and lysed by sonication 
with First Dimension Buffer containing 8.0M Urea, 
2.0% Triton X-100, 5% β-mercaptoethanol, 1.6% 
Bio-Lyte 5/7 and 0.4% Bio-Lyte3/10 ampholytes, 
1,5% CHAPS. Samples were isoelectrofocused on 4% 
PAGE (T=25%, C=3%), supplemented with 8M Urea 
1.5% CHAPS at pH range of 4 – 9. Isoelectrofocusing 
gels were than transferred on top of gradient 4 – 15% 
SDS – PAGE for second dimension. Blots were 
probed with Goat anti – p47phox antibody. For the 
second hybridization, blots were probed with Donkey 
anti – Goat monoclonal antibodies (Li-Cor), labeled 
with IR – dye 800CW. Membrane was scanned with 
infrared scanner Licor Odyssey and analyzed with 
Odyssey 2.1 software.  
 
Sub fractionation of protein extracts – Total protein 
was isolated from control and p66Shc(-/-) PM 
induced with PMA for 5 minutes or mock treated as 
described above. Cells were collected and lysed by 20 
strokes in CHAPS lysis buffer containing 20mM Tris-
HCl (pH 7.5), 150 mM NaCl, 10% Glycerol, 0.5% 
CHAPS and supplemented with Complete Mini 
Protease Inhibitor Cocktail and PhosStop Phosphatase 
Inhibitor Cocktail (Roshe). Unbroken cells were 
collected by brief centrifugation at 400g and protein 
concentrations were determined. 100 µg of total 
protein were adjusted to 60 µl with CHAPS lysis 
buffer and centrifuged at one hundred thousand 
gravity force during 30 minutes at +4◦C. Supernatant 
was called cytosolic fraction and pellet was washed 
with CHAPS lysis buffer and contained membrane 
fraction of proteins. Cytosolic fraction was 
supplemented until 1X with Laemmli Sample Buffer, 
membrane fraction was resuspended in 1X Laemmli 
Sample Buffer. Fractions were boiled till dissolved 
completely and loaded on SDS PAGE. Western Blots 
with indicated antibody were performed as described 
above. 
 
Rac activation assay – Macrophages were 
isolated from 3 month old mice as described 
above and 7X106 cells were resuspended in 6 ml 
of KRP media. Three ml of cell suspension were 
induced with stimulus: 3 µg/ml of PMA for 5 
minutes or 5 µM fMLP for 60 seconds, as 
indicated; other half of three ml cell suspension 
were treated with equal amount of DMSO (Mock 
treatment). For fMLP induction cells were 
pretreated with 10 µM cytochalasin b for 10 
minutes. Reactions were stopped by 5 volumes 
dilution of ice cold PBS, cells were collected by 
rapid centrifugation and lysed in ice cold lysis 
buffer: 25 mM HEPES pH=7.5, 150mM NaCl, 
1% Igepal CA 630, 10% glycerol, 25 mM NaF, 
10 mM MgCl2, 1 mM EDTA, 1 mM Sodium 
orthovanadate, and Complete Mini proteinase 
inhibitor cocktail (Roshe, Mannheim). Lysates 
were rapidly clarified by low speed centrifugation 
at +4◦C and immediately frozen in liquid nitrogen 
until use. Aliquots of protein lysates were left for 
protein quantification. 
GTP-Rac1/2 was precipitated using Rac/cdc41 
Assay Reagent PAK-1 PBD agarose conjugate 
(Millipore, Temecula, CA) from equal amounts 
of protein as recommended by manufacturer. For 
the positive controls 1/3 aliquots of each 
experimental sample were loaded with 100 µM of 
GTPγS for 10 minutes at 30◦C and than used for 
precipitation with PAK-1 PBD agarose. Positive 
control samples were used to estimate total Rac 
available for GTP-binding in a sample and to 
ensure that affinity reagent is not saturated. 
Precipitates were resolved on 15% SDS PAGE, 
and blots were probed with mouse anti-Rac1 
monoclonal (Millipore, Temecula, CA) and Goat 
anti-Rac2 polyclonal antibody (Abcam Inc, 
Cambridge, MA). Blots were developed and 
quantified using infrared labeled secondary 
antibodies as described above. Fluorescent 
arbitrary units from Rac bands were normalized 
to a 50 kD constitutive band of constant intensity 
between all samples regardless GTPγS loading of 
lysates. 
 
Results 
p66Shc-deficient mice have transcriptional 
alterations in phosphatidylinositol and heme 
pathways. 
To identify transcripts altered in long-lived p66Shc 
knockout mice, we microarrayed RNA from liver, 
spleen, lungs, fat and peritoneal macrophages, of 3 
month old males and 12 month old males and females 
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of p66Shc(-/-) and control mice. A total of 19 
mutants- and 19 age/sex-matched control animals 
were used for the hybridization with Affymetrix 
oligo-microarray chips followed by analysis of gene 
expression data using dChip [10]. Each dataset was 
analyzed individually and transcripts of p< 0.05, were 
organized in a megatable, and the top 250 up- and 
down-regulated genes were entered into OntoExpress 
[12] as described in methods. The top four 
significantly altered pathways are presented.  Also, 
lists of top 100 up- and down- regulated genes were 
analyzed with OntoExpress for biological process 
[11]. Table of the top four regulated bioprocesses are 
shown (Table 1). 
PI3Kinase and antigen processing were significantly 
altered pathways, impact factors 35 and 28, and heme 
transcripts were preferentially affected.  Some of the 
genes underlying these down-regulated processes 
were related to NADPH Oxidase activity. Given the 
involvement of heme in NADPH Oxidase-dependent 
ROS production, this activity was specifically 
measured. 
 
p66Shc(-/-) macrophages have a defect in NAD(P)H 
oxidase dependent ROS generation. 
NADPH oxidase (PHOX) is the basis of the 
respiratory burst. We measured the respiratory burst 
of p66Shc(-/-) peritoneal macrophages by two 
different methods: the conventional SOD-inhibitable 
reduction of cytochrome c assay, and a more 
sensitive, fluorescence-based H2HFF-oxidation assay, 
(Figure 1). Both H2HFF dye oxidation and 
cytochrome c reduction were inhibitable with 
diphenyliodonium (DPI) or gliotoxin, specific PHOX 
inhibitors [13-16]. As determined by the cytochrome 
c assay, mean values of SOD-inhibitable superoxide 
production by 600,000 PMA-induced control 
macrophages was 151 pMol superoxide/minute, 
whereas p66Shc(-/-) macrophages produce 104 pMol 
superoxide/min. Thus, mutant macrophages have 69% 
of the NAD(P)H – oxidase activity of control. The 
difference in means was  significant, p<0.000003 
(Figure 2A). Similarly, the H2HFF oxidation method 
demonstrated about 40% defect in superoxide 
production by mutant macrophages, p value 0.01084 
(Figure 2 B). Similar results were obtained for fMLP 
and arachidonic acid (AA)-stimulated macrophages 
(Figure 2 C, D).  Similar results were also obtained 
for p66Shc(-/-) mice in the 129 genetic background 
using the DCFDA assay. 
 
P66Shc-null mice have no defects in expression levels 
of NOX2 subunits. 
There are at least three explanations for a p66Shc-
dependent defect in PMA-stimulated NAD(P)H – 
oxidase activity, i.e. a defect in expression in a PHOX 
component, in the heme necessary for superoxide 
production, or the rate of activation of the complex.  
First, we investigated the expression of the 
components of NOX2 complex, i.e. Rac1/2, p40phox, 
p47phox, p67phox p22phox or gp91phox, using 
western blots of protein extracts from peritoneal 
macrophages of p66Shc(-/-) and control mice (Figure 
3 and data not shown). There was no significant 
decrease in protein levels of any tested NOX2 subunit 
in mutant macrophages versus control.  Thus, the 
defect in PHOX activity in mutant p66Shc(-/-) cells 
could not be explained by a defect in NOX2 subunit 
levels.   
 
Heme levels are unchanged in mutant mice blood. 
Heme deficiency causes delayed maturation and 
degradation of gp91phox, result in reduced gp91phox 
protein level in mammalian cells [17, 18]. Microarray 
results suggested a heme defect in p66Shc mice. 
However, since there was no difference between 
gp91phox abundance in mutant and control 
macrophages, it was unlikely that heme level would 
be different in p66Shc(-/-) mice. We investigated total 
blood heme levels, in p66Shc(-/-) mice vs. littermate 
controls.  No significant difference was observed 
(Figure 4). 
 
p66Shc(-/-) cells have reduced  phosphorylation of 
p47phox. Since there was no deficiency in expression 
of cytosolic NOX2 subunits in the p66Shc(-/-) mice, 
no deficiency in membrane subunit gp91phox, and no 
heme deficiency, remaining explanations for the 
decreased level of PHOX activity included a 
reduction in phosphorylation of the main regulatory 
subunit p47phox, or reduced Rac – activation. After 
induction of macrophages with PMA or fMLP, 
p47phox becomes rapidly phosphorylated. The 
autoinhibitory domain [19] of p47phox contains four 
clusters of serine residues. Each cluster contains two 
or three Ser residues, separated by few amino – acids 
(ten serines totally) [20]. This phosphorylation 
induces the ultimate translocation of p47phox and 
p67phox, existing as a complex with p40phox in 
cytosol, to the heme-containing catalytic subunit 
gp91phox. The phosphorylation rate of p47phox is 
one of the limiting steps for the assembly and 
activation of PHOX [21]. The last phosphorylation 
step occurs only after p47phox translocates and 
associates with p22phox [22]. At the same time, 
GDP-GTP exchange factors Rac1 or Rac2 activate 
and translocates to the cytochrome b558. 
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We measured phosphorylation rates of p47phox in 
PMA-induced macrophages from p66Shc(-/-) and 
control macrophages by two dimensional 
electrophoresis, as described in methods, followed by 
western blot with anti-p47phox antibody (Figure 5 A). 
The isoelectric point (IEF) for non – phosphorylated 
p47phox is 9.07. Upon phosphorylation, the IEF of 
the protein shifts towards acidic pH due to increasing 
number of PO43- residues attached to the protein.  
On mock treatment without PMA we observed a spot 
at molecular mass 47 kD and pH about 9, 
corresponding to p47phox and labeled with state “0” 
of phosphorylation. Upon PMA treatment for 5 
minutes 4 spots appeared at molecular mass 47 kD 
with more acidic IEF, corresponding to higher 
phosphorylation states of p47phox. While only 22% 
of p47phox from wild-type PM remained 
unphosphorylated after 5 minutes treatment with 
PMA, 55% from mutant PM was unphosphorylated 
((Figure 5 B).  Consistently, mutants had about a 40% 
decrease in the phosphorylated isoforms of p47phox.  
Of the phosphorylated forms, p66Shc mutants had a 
higher fraction of p47phox in state 1 and 2 (30%) than 
controls that had a higher fraction of p47phox in 
phosphorylation states 3 and 4. Since the final 
phosphorylation step of p47phox occurs only after 
PHOX is fully assembled, we suggest that assembly 
of NAD(P)H – oxidase is reduced in p66Shc(-/-) cells.  
The 40% reduction in phosphorylation rate is 
sufficient to explain the 40% reduced rate of ROS 
production from p66Shc-deficient mice. 
 
p66Shc(-/-) macrophages have reduced translocation 
of p47phox.  We investigated PMA inducible 
translocation of p47phox to plasma membrane using 
ultracentrifugation to separate total protein from 
mutant and control macrophages on membrane and 
cytosolic fractions in five experiments. Cytosolic and 
membrane fractions were then resolved on SDS 
PAGE, a very slight MnSOD signal was observed in 
membrane fraction of PM protein extracts from both 
mutant and control mice, supporting that only very 
slight contamination (<1%) of membrane fraction by 
proteins from cytosolic fraction occurred. Beta actin 
bands (loading control) were present in all fractions. 
P47phox was about 35% less abundant membrane 
fractions of PMA-stimulated mutant macrophages vs. 
controls. Mock treated PM had similar levels of 
p47phox in membrane fraction. In some experiments 
membrane fractions were sonicated with SDS prior to 
SDS PAGE analysis, under these conditions 
membrane p47phox fraction migrated at the same 
molecular weight as cytosolic p47phox, 
demonstrating the PMA-dependent shift in p47phox’s 
molecular weight (Figure 6) and data not shown).  
The proteins for the experiment were isolated under 
mild lysis conditions with agent CHAPS in 
concentration of 0.5% as described in materials and 
methods (Fig. 6). After centrifugation of cleared 
lysates at 100,000g precipitates of membrane-
associated proteins were tight and hard to dissolve. 
On the blot presented the shift in membrane fraction 
p47phox mobility on SDS-PAGE is large; also, 
p47phox runs as a doublet. We suggest that this was 
the result of incomplete penetration of loading buffer 
components into the pellet. We performed five similar 
independent experiments in which precipitates of 
membrane fraction were sonicated in loading buffer, 
boiled and loaded on the gel. The shift in mobility of 
p47phox was also apparent under these conditions, 
and membrane-associated p47phox was running at its 
expected mass as single band. We present the blot 
where membrane-associated p47phox ran slower 
because we suggest that this shift in mobility provides 
one more internal control for contamination of 
membrane fraction by cytosolic fraction. The doublet 
bands corresponding to membrane-associated 
p47phox were added and normalized to beta actin 
levels to correct for loading.  
We suggest that reduced translocation of p47phox in 
mutant cells is the result of reduced phosphorylation 
of p47phox in p66Shc(-/-) mice, and could explain 
reduced superoxide generation by PM from p66Shc(-
/-) mice. 
 
siRNA-mediated p66Shc knockdown decreases 
NADPH-oxidase dependent superoxide generation. 
To address whether the defect in NADPH Oxidase-
dependent superoxide production was a direct 
consequence of p66Shc, we knocked down p66Shc in 
the mouse macrophage cell line RAW264. In 25 
independent transfections, we observed a mean 
reduction p66Shc of 40% and 60% at the mRNA and 
protein levels, respectively (Figure 7). P66Shc siRNA 
did not affect expression of NADPH-oxidase subunits 
or other p52 kD and p46 kD Shc isoforms at the 
protein level (Figure 7 and data not shown). The 
p66Shc – silenced RAW264.7 cells has about 30% 
reduction in PMA – inducible H2HFF dye oxidation, 
which was inhibitable with DPI or Gliotoxin. We 
conclude that p66Shc deficiency is sufficient for 
partial defect in activation of NAD(P)H – oxidase. 
p66Shc(-/-) macrophages do not have a big defect in 
Rac activation. Another component of NADPH 
oxidase activation in phagocytic cells is GTPase Rac 
[23, 24].  Correct positioning of p67phox with 
gp91phox depends mostly on two regulatory subunits: 
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p47phox and Rac1 or Rac2 [21]. Defect in activation 
of either one will lead to defect in NADPH oxidase 
activity. In our experiments we observed a decrease in 
activation and translocation of p47phox, however, if 
Rac activation was reduced as a consequence of 
altered Shc, it would lead to decrease in NADPH 
oxidase activation. 
We tested activation of both Rac1 and Rac2 by fMLP 
and PMA. The maximal rate of Rac activation by 
PMA is five minutes, and one minute of fMLP 
treatment [25]. We found no difference in PMA-
stimulated Rac1 activation between p66Shc(-/-) and 
wild type macrophages. A very small (1.18 times), but 
significant (p=0.023346) reduction in Rac1 activation 
was found in fMLP-stimulated mutant macrophages 
(Figure 8).  Since p66Shc was reported to signal 
specifically to Rac1, and Rac1 is four times more 
abundant in peritoneal macrophages then Rac2 [26], 
we present blots measuring GTP-Rac1. GTP-Rac2 
also precipitated with the PAK-1 PBD agarose 
conjugate and we tested GTP-Rac2 levels as well. 
Rac2 activation by PMA and fMLP was not different 
from Rac1 activation (data not shown). GTP-Rac 
bands have similar intensities between p66Shc(-/-) 
and wild type agonist-stimulated macrophages. A 
slight difference with fMLP stimulation was revealed 
only after densitometry and normalization to the 
loading control bands. Statistical analysis of four 
independent experiments with two technical replicates 
each (eight gels total) showed that p66Shc(-/-) 
macrophages have a very slightly less fMLP induced 
Rac1 activation, whereas PMA stimulation results in 
no statistically different activation of Rac in mutants 
and wild type macrophages. 
The decrease in respiratory burst between mutant and 
wild type macrophages was 30-35% and was 
observed with fMLP, PMA and arachidonic acid 
stimulation. We conclude that difference in Rac 
activation could not explain the difference in 
oxidative burst between mutant and control 
macrophages. 
 
p66Shc(-/-) cells have reduced phosphorylation of 
PrkCδ. PMA through translocation to the plasma 
membrane drives phosphorylation of protein kinases 
C (PKC)  and phosphorylation of its targets. PKCδ is 
thought to play a central role in activation of PHOXes 
by phorbol esters [27]. We measured the activation of 
PKCδ in mutant and control macrophages induced 
with PMA. A western blot, representing 18 similar 
experiments, is shown (Figure 9 A). The primary 
antibodies for total PKCδ were from mouse and 
primary antibodies for the phospho-PKCδ were from 
rabbit host species. We used secondary antibody 
labeled with different infrared dyes as described in 
methods section. This creates the possibility to run 
total PKCδ (loading control) and phospho-PKCδ 
quantification on the same membrane. We measured 
band intensities for phospho PKCδ and total PKCδ on 
our Western blots. Bars on the graph presented on 
picture (Figure 9 B) are intensities of phospho PKC 
delta divided by PKC delta. Error bars are standard 
deviations of 18 experiments. On the Western blot 
(Figure 9 A), the bands corresponding to p66Shc(-/-) 
PMA induced phospho-PKCδ looks lighter than 
control ones. As shown on the bar graph, PMA-
stimulated PKCδ phosphorylation in mutant 
macrophages was significantly reduced for about 30% 
comparing to control macrophages ones, p-value 
0.017. In mock-treated macrophages no significant 
difference in phospho – PKCδ abundance in mutant 
macrophages versus control was observed, p – value 
0.91 (Figure 9 B). Since the difference in ROS 
production is only 30-40%, we didn’t expect a bigger 
defect in phosphorylation of PKC delta. Thus, the 
defect in NADPH oxidase activation in p66Shc(-/-) 
cells can be explained by a decrease in 
phosphorylation rate of PKCδ and, as a result, 
decrease in activation of p47phox. 
 
p66Shc-/- marophages have reduced activation of 
Akt and ERK by fMLP. A number of kinases have 
been proposed to participate in p47phox 
phosphorylation events, among which Akt and 
ERK have being reported [28-30]. We tested Akt 
and ERK activation after one minute of fMLP 
treatment in mutant and control macrophages 
using anti-phospho Akt, anti-total Akt, anti-
phospho ERK and anti-total ERK antibody. The 
antibodies were from different species and, it was 
possible to analyze phospho-specific and total 
antigen specific bands on the same membrane at 
the same time. The activation of Akt and ERK 
was lower in mutant macrophages (Figure 10) 
p=0.029532, and p=0.046206 respectively. The 
difference in PKC activation between p66Shc(-/-) 
and wild type cells in our experiments was about 
30%. The difference in Akt and ERK activation 
was about 30% also. We suggest that since Akt 
and ERKs have been reported to be activators of 
p47Phox, decreased phosphorylation of Akt/ERK 
in p66Shc-deficient mice contributes to decreased 
activation of p47Phox. 
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Discussion 
Long-lived 66Shc-deficient mice produce less 
superoxide through macrophage NADPH oxidase. 
p66Shc-deficient mice have an extended lifespan, and 
their cells produce less ROS, and are resistant to 
oxidative stress. We sought to identify the basis of the 
extended lifespan. We observe that the NADPH-
dependent production of superoxide is deficient in 
p66Shc KO mice.  The defect does not appear to 
result from any deficiency in PHOX protein 
expression but rather through a Shc-dependent defect 
in the signaling and phosphorylation and assembly of 
the PHOX complex. Resistances to oxidative stress, 
altered insulin sensitivity and reduced body mass have 
been reported for multiple mouse longevity models 
[31]. We suggest that reduced NADPH-oxidase 
dependent superoxide production could be the basis 
for reduced inflammatory and oxidative disease in 
these long-lived mutants, and could contribute to their 
increased lifespan. 
 
Activation of p47phox and kinases, implicated in 
p47phox phosphorylation, are lower in p66Shc(-/-) 
mice.  The deficiency in NADPH Oxidase-mediated 
superoxide production in mutant mice could have 
been the result of several p66Shc-dependent causes: 
deficiency in PHOX subunits or heme.  However, we 
observed no evidence of deficiency of PHOX related 
proteins or heme.  By contrast, the phosphorylation 
rate of p47phox was clearly and significantly lower in 
mutants compared to controls.  
A number of kinases have been proposed to 
participate in p47phox phosphorylation events, in 
particular, protein kinase C (PKC), mitogen-activated 
protein kinases (MAPKs) [20], extracellular signal-
regulated kinase (ERK1/2) [28], p21-activated kinase 
(PAK) [32, 33] and protein kinase B (PKB)/Akt [29, 
30]. Since we did not observe a big difference 
between p66Shc KO and WT macrophages in 
activation of Rac, we do not expect activation of 
PAK, which is downstream of Rac. fMLP treatment 
of phagocytic cells leads to activation of Src related 
kinase Lyn [34] and Syk. Shc proteins are 
downstream and implicated in signaling to Akt and 
ERK through binding to Grb2, SOS and activation of 
Ras in phagocytic cells [35, 36]. Major signal 
conductors were reported to be p52Shc and p66Shc 
[37]. However, this is not the only way for activation 
of ERK and MAPK in hematopoietic cells [38]. In the 
p66Shc KO background, changes in Shc expression 
could affect activation of PI3K, Akt and ERK.  
In our experiments we observed that level of 
activation of PKCδ was lower in mutants. PKCδ is 
critical for phosphorylation of p47phox [27, 39]. It 
has been shown that Shc directly interacts, co-
localizes and co-translocates with PKCδ in different 
type of cells including MEFS [40], hematopoietic 
cells [41], pancreatic cells [42], COS cells [43]. Upon 
stress, p52Shc and especially p66Shc [43] gets 
phosphorylated by PKCδ, p46Shc has been shown to 
be similarly phosphorylated by PKCδ as p66Shc. 
Thus, there is clear connection of Shc proteins to PKC 
signaling and changes in expression of Shcs are 
expected to affect PKC activation rates, as we observe 
in p66Shc (-/-) cells. 
Akt and ERK kinases are downstream of Shc proteins 
in signaling cascades. Thus, defect in expression of 
Shc would lead to defect in signaling to Akt and ERK 
through Shc/Grb2/SOS/Ras/PI3K pathway. In our 
experiments we observed such defects as decreased 
activation of Akt and ERK for about 30%. We 
propose that defect in PKCδ, Akt and ERK activation 
contributes to the defect in p47phox phosphorylation, 
and ultimately to the defect in PHOX activation and 
superoxide production.  
 
Rac activation is similar in p66Shc (-/-) macrophages. 
Another component crucially important for efficiency 
of NADPH oxidase activation in phagocytic cells is 
GTPase Rac [23, 24].  Studies shown that p66Shc 
redirects the signaling of Shc through SOS toward 
Rac1 activation and consequently leads to ROS 
production in mouse embryonic fibroblasts (MEFS) in 
response to stress [44]. Activated Rac, in turn, has 
being reported to increase phosphorylation, reduce 
ubiquitination and stabilize p66Shc protein [45]. 
P67phox was reported to be effector of both Rac1 and 
Rac2. In macrophages mostly Rac1 is responsible for 
NADPH oxidase activation [46]. Moreover, binding 
of Rac- or Cdc42-GTP leads to PAK auto-
phosphorylation and activation of the ability to 
phosphorylate exogenous substrates on serine and/or 
threonine residues. Substrates for PAK in human 
neutrophils may include the p47phox and p67phox - 
NADPH oxidase components [32, 47]. Thus, defect in 
Rac/PAK-1 activation would lead to defect in 
p47phox phosphorylation. Also, defect in Rac 
activation itself would lead to defect in p67phox 
assembly with gp91phox. 
In our experiments GTP-Rac levels in p66Shc(-/-) and 
wild type agonist stimulated macrophages were 
similar. A very slight decrease with fMLP stimulation 
was observed. PMA simulation resulted in no 
significant difference in activation of Rac in mutants 
and wild type macrophages.  However the 30-40% 
decrease in respiratory burst in mutant macrophages 
was observed with all stimulators: fMLP, PMA and 
arachidonic acid. We conclude that difference in Rac 
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activation cannotexplain the difference in oxidative 
burst between mutant and control macrophages.  
It has been shown that p66Shc signals to Rac1 and 
leads to ROS production in some cell types. In our 
study we saw only a tiny effect of p66Shc deletion on 
Rac activation in peritoneal macrophages. The 
p66Shc level in wild type macrophages is very small 
and is very similar to the Shc levels in RAW-cells 
(Figure 7), <1% compared to the other isoforms p52 
and p46 Shc. However Mouse Embryonic Fibroblasts 
have very high p66Shc levels, such that 
p66=p52=p46[45] and our data not shown. This is a 
potential explanation for the different results obtained 
in current study on macrophages and a former study 
employing MEFS [44]. 
 
G protein-coupled receptors, Shc and NADPH 
Oxidase activity. Agonists activate G protein-coupled 
receptors (GPCRs) - the Gi family of heterotrimeric G 
proteins in hematopoietic cells which are composed of 
Gα, Gβ, and Gγ subunits. Ligand binding to receptors 
catalyzes the GDP for GTP exchange on the Gα 
subunit, liberating it from the Gβγ complex. Free Gβ, 
and Gγ subunits directly bounds to downstream 
effectors [48] and direct functions including 
chemotaxis and superoxide production [49]. Thus, 
GPCR signals to phosphoinositide 3-kinase-γ (PI3Kγ) 
[50] with subsequent synthesis of phosphatidylinositol 
-3’, 4’, 5’- triphosphate (PIP3) followed by PIP3 
activated kinase (PDK) and Akt activation. Akt is one 
of the activators of p47phox [29, 30]. PIP3 required 
for the activation of GEF – DOCK-2 and for the 
anchoring of p47phox and p40phox on the membrane 
during NADPH-oxidase assembly [51-55]. Activation 
of PI3K has being reported to require active Ras, 
which is downstream of Shcs. Shcs are activated by  
GPCRs through tyrosine kinases Lyn and Syk [34, 35, 
56] and cause GRB2/SOS/Ras/Raf/MEK-dependent 
ERK activation. ERKs are activators of p47phox [28].  
Active Gβγ’s also activate phosphoinositide-specific 
phospholipase-β (PLCβ) [57, 58], which, in turn, lead 
to generation of inositol trisphosphate (IP3), with the 
consequent mobilization of Ca2+ from intracellular 
stores, and diacylglycerol (DAG), with the 
consequent activation of various protein kinase C 
(PKC) isoforms, including  DAG-sensitive calcium 
dependent kinase-PKCδ. It have being demonstrated 
that PKCδ, on one hand directly interacts with Shc 
[40-43].  Also, PKCδ is an activator of p47phox [27, 
39, 59, 60]. 
Thus, activations of PKCδ, Akt and ERKs are 
dependent on activation and expression of Shcs. On 
another arm of the pathway, GPCR signals to GTP 
Exchange Factor (GEF) – Vav through the Src Family 
kinases Hck and Fgr and cause GDP-GTP exchange 
and activation of Rac GTP-ase, leading to Rac 
translocation and participation on NADPH-oxidase 
assembly [58]. Also, activated Rac signal to PAK-1, 
which has been reported to be a p47phox, a NADPH-
oxidase regulatory subunit, activator [32, 33]. One 
more way in which GPCR activates Rac is through 
the direct activation of GEF–P-Rex by the free Gβγ 
[61], however, this requires PIP3. Thus, Rac 
activation could has the potential bypass the Shc-
dependent pathways (Figure 11). 
So, we observe a Shc-dependent defect in activation 
of PKCδ, Akt and ERK with consequent effect on 
activation of p47phox, consistent with defective 
activation of the right and center arms of the pathway 
descending from Gi stimulation.  We only observe a 
very slight decrease in GTP-Rac binding (the left arm 
and non-Shc dependent part of the pathway), and this 
defect is not sufficient to explain the 30-40% decrease 
in NADPH Oxidase-dependent superoxide 
production.  
 
Potential consequences of NADPH-oxidase deficiency 
in p66Shc(-/-) mice. Reduced ROS production and 
resistance to oxidative stress has also been reported to 
extend lifespan in several invertebrate model systems 
[62-67].   Resistance to oxidative stress, altered 
insulin sensitivity and reduced body mass has been 
reported for multiple mouse longevity models [31]. 
However the support for longevity as a result of 
increased protection from oxidative stress in rodents 
is mixed.  While CuZnSOD and MnSOD deficiency 
cause increased ROS in vivo and shortened lifespan 
[68, 69], overexpression of CuZnSOD and MnSOD 
does not appear to extend mouse lifespan [70-72]. 
However, increased mitochondrial catalase expression 
has been reported to increase lifespan and healthspan 
in mice [73, 74], and increased CuZnSOD in rats 
increases lifespan (Richardson, personal 
communication). 
p66Shc-deficient mice have been observed to be 
resistant to several types of age-related pathology 
associated with oxidative stress and/or inflammation 
(which can be caused by phagocytic cells), including 
vascular disease [5], age related endothelial 
dysfunction [75], oxidative inflammatory kidney 
damage [8, 76], hyperglycemia-induced endothelial 
dysfunction and oxidative stress [7], and brain 
oxidative stress [77]. This resistance could be the 
result of decreased oxidative stress, or decreased 
inflammatory response. Two major sources of cellular 
ROS production are NADPH Oxidase (PHOX) and 
mitochondria. A small decrease in CCL4-dependent 
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mitochondrial ROS generation was shown previously 
for p66ShcKO mice [4]; however, PHOX- dependent 
superoxide production has not been investigated. 
We observe that the NADPH-dependent production of 
superoxide is deficient in p66Shc mice.  The defect 
does not appear to result from any deficiency in 
PHOX protein expression but rather through a Shc-
dependent defect in the signaling and phosphorylation 
and assembly of the PHOX complex.  This defect in 
PHOX-dependent superoxide generation has the 
potential to explain the reported resistance of p66Shc 
knockout mice to oxidative pathologies in endothelial 
cells, kidney and brain, and could also underlie the 
relative sensitivity of p66Shc mice to insulin and their 
longevity. Further studies are necessary to clarify the 
role of reduced oxidative stress in longevity.  
In the present work we demonstrate that ROS 
production by NADPH-oxidase is deficient in p66Shc 
knockouts. We suggest that reduced NADPH-oxidase 
dependent superoxide production could be the basis 
for reduced inflammatory and oxidative disease in 
these long-lived mutants. Activation of NADPH 
oxidase and inflammation is perhaps the most clear 
example of antagonistic pleiotropy [78], i.e. an 
increase in ROS production is protective at a young 
age but causes multiple age related pathologies, 
including atherosclerosis, hypertension, nephropathy 
rheumatoid arthritis, [79]. An increase in several 
markers of inflammation with age is observed in 
many species including human, and is thought to 
cause lifespan-limiting pathology, in inflammatory 
hypotheses of aging [80-83] with special emphasis on 
phagocytic cells [84]. Multiple anti-inflammatory 
changes occur in long-lived Ames dwarf mice [85].  
Dietary restriction appears to decrease inflammation 
and it is thought that this is one mechanism by which 
it increases lifespan [86]. Anti-inflammatory drugs 
can block age-related pathology, neuro-degeneration 
and extend lifespan in several species, including mice 
[87-90] and drosophila [91]. We suggest that reduced 
NADPH oxidase activity could contribute to reduced 
inflammation in p66Shc KO mice and underlie their 
increased lifespan. 
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Figure legends. 
 
Table 1. Genomic effects of p66Shc knock out. Lists of top significant up or down-regulated 
genes through p66Shc -/- mice tissues: Spleen, Retroperitoneal fat, Liver, Lungs, Peritoneal 
macrophages, Epididymal fat, at both ages of 3 month and 12 month were submitted to 
“OntoExpress”, as described in methods. Outputs of “Pathway analysis tool” and “Bioprocess 
analysis tool” were truncated to top most significant fore in each category and presented in the 
table format. 
 
Figure 1. Six hundred thousand peritoneal macrophages pre-incubated or not, as indicated, with 
gliotoxin were resuspended in KRP media, containing H2HFF-BSA dye according to dye 
manufacturer instructions. Initial readings at excitation 480 nm and emission 520 nm were 
taken during first 12 minutes. PMA was added at point shown by arrow, and readings were 
taken during next 30 minutes. Error bars are standard error, N=2. 
 
Figure 2. NAD(P)H oxidase activity in Peritoneal Macrophages from control and p66Shc(-/-) 
mice. A. Superoxide generation by PMA – induced peritoneal macrophages from p66Shc(-/-) 
and control mice, as indicated, was assayed using SOD – inhibitable cytochrome – c reduction 
assay. Bars represent mean amount of superoxide (pMol) per minute per 600 thousands cells. 
Error bars are standard deviations. N=12. B. Superoxide generation by PMA – induced 
peritoneal macrophages from p66Shc(-/-) and control mice, as indicated, was assayed using 
H2HFF fluorescent dye oxidation method. Bars represents mean of slopes of fluorescence 
increase (excitation 480 nm, emission 530 nm) after PMA induction of macrophages. Non-
induced cells were used as the baseline. C. Superoxide generation by fMLP – induced 
peritoneal macrophages from p66Shc(-/-) and control mice, as indicated, was assayed using 
H2HFF fluorescent dye oxidation method. D. Superoxide generation by AA – induced 
peritoneal macrophages from p66Shc(-/-) and control mice, as indicated, was assayed using 
H2HFF fluorescent dye oxidation method. Error bars are standard deviations. For H2HFF dye 
oxidation method N=4. 
 
Figure 3. Total protein was extracted from mouse peritoneal macrophages of control and 
p66Shc(-/-) mice, mock – treated or treated with PMA, or pretreated with gliotoxin and treated 
with PMA, as indicated. Blots were probed with Rabbit polyclonal antibody to p40phox, 
p47phox, p67phox and gp91phox. At the same time blots were probed with Mouse anti – actin 
beta. Bands of the NAD(P)H – oxidase components and beta actin are indicated.  
 
Figure 4. Heme levels in blood of p66Shc(-/-) mice and control mice. Bars represents total heme 
presented as percent (g) in blood of fore p66Shc(-/-) and fore Control mice; two p66Shc(-/-) 
and Controls was at ages of 3 month and two – 12 month. Error bars are standard deviations. 
N=4. 
 
Figure 5. p66Shc(-/-) cells have reduced  phosphorylation of p47phox. Total protein was isolated 
from control or p66Shc(-/-) macrophages induced with DMSO (Mock treatment) or PMA for 5 
minutes, as indicated. Samples were isoelectrofocused at pH range of 4 – 9. Isoelectrofocusing 
gels were transferred on top of SDS – PAGE for second dimension. Blots were probed with 
Goat anti – p47phox antibody. Phosphorylated (1, 2, 3, 4) and Non-phosphorylated (0) forms 
of p47phox are indicated. B. Bars represent densitometry results for the levels of 
Phosphorylated p47phox expressed as part of total amounts of p47phox, N=2. 
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Figure 6. p66Shc(-/-) macrophages have defect in translocation of p47phox to membrane upon 
PMA induction. A. Total protein was isolated from control or p66Shc(-/-) macrophages 
induced with DMSO (mock treatment) or PMA for 5 minutes, as indicated. Samples were 
cleaned from unbroken cells by centrifugation and than were separated on membrane and 
cytosolic fraction by ultracentrifugation at 100.000 X g. as described in methods section. 
Cytosolic and membrane fractions were then resolved on SDS PAGE and transferred to 
nitrocellulose membrane. Membrane was cut by 35 kD marker band and upper part was probed 
with goat anti p47phox polyclonal antibody and mouse anti actin beta primary antibodies. 
Lower part was probed with anti MnSOD primary antibody. Western Blot image of one out of 
five experiments is presented. B. Bars on the graf represent means of fluorescence intensities of 
p47phox bands from membrane fraction divided to fluorescence levels of actin beta bands. 
Error bars are standard deviations, N=5.  
 
Figure 7. p66Shc(-/-) macrophages have reduced phosphorylation rate of PrkCδ. A. Western blots 
of control or p66Shc(-/-) peritoneal macrophages DMSO (Mock treated) or PMA - treated, as 
indicated, were probed with rabbit anti prkCd and rabbit anti phospho-prkCd antibody. Bands 
of prkCd and phospho-prkCd are indicated. B. Bars represent densitometry result for the blot, 
and are the levels of phospho-prkCd normalized to total prkCd. N=18, p-value = 1.7E-02 
 
Figure 8. Mouse macrophage cell line RAW 264 with siRNA mediated p66Shc knock down have 
defect in NAD(P)H-oxidase dependent superoxide generation. A. Isoform specific siRNA 
mediated Knock Down of p66Shc in RAW264 cells. Total protein was extracted 48 hours after 
transfection with p66Shc siRNA or Control siRNA, as indicated. Blot was probed with Rabbit 
polyclonal anti-ShcA antibody. B. Bars represent the amount of p66Shc as percent of all three 
Shc isoforms. C. QRTPCR results of p66Shc expression measures normalized to beta actin 
levels, N=25. D. NAD(P)H-oxidase activity in p66Shc KD and control RAW264 cells. Bars 
represent the means of slopes of fluorescence increase of H2HFF dye after PMA induction. 
Non-PMA induced cells were used as baseline. Error bars are standard deviations, N=25. 
 
Figure 9.  p66Shc(-/-) macrophages do not have a big defect in Rac1/2 activation. A. Precipitates 
of Rac1/2 were prepared from PMA and Mock treated macrophages of p66Shc(-/-) and Control 
mice as described in methods section, resolved by SDS PAGE, and blots were probed with 
mouse monoclonal anti-Rac1 primary antibody. Presented is one of three independent blots. 
Rac1 and loading control bands, “mock treated”, PMA treated (five minutes 3 µg/ml) samples 
and GTPγS loaded samples are indicated. B. Similar experiments as on panel A, but performed 
with 60 seconds 10 µM fMLP stimulation. C. Bars represent levels of GTP-Rac1 normalized 
by loading control band. Between experiments normalization was performed using 
experimental mean of each experiment. Error bars are SE, N=3. D. Similar to panel C. but 
experiments performed with fMLP stimulation. N=8. 
 
Figure 10.  p66Shc(-/-) macrophages have lower fMLP induced Akt activation. A. Macrophages 
from mutant and control mice were induced with fMLP as described above, reaction was 
stopped by dilution 5 times with ice cold PBS and cells were lysed with ice cold lysis buffer as 
for the Rac activation assay. Western blot was hybridized with mouse anti-phospho Akt and 
with rabbit anti-total Akt antibody at the same time and developed using Licor imaging system 
as described above. B. Bands corresponding to phospho Akt and total Akt were quantified, and 
intensities of phospho Akt bands were divided by intensities of total Akt bands. Bars are result 
of tree independent measurements. Error bars are standard deviations. 
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Figure 11. Simplified schema of NADPH-oxidase activation. Agonists activate G protein-coupled 
receptors (GPCRs) - the Gi family of heterotrimeric G proteins in hematopoietic cells. Ligand 
binding to receptors catalyzes liberating the Gβγ complex. Free Gβ, and Gγ subunits signals to 
following signal transduction pathways: (PI3Kγ)/(PIP3)/PDK/Akt/p47phox, 
(Lyn,Syk)/Shc/Grb2/SOS/Ras/Raf/MEK/ERK/p47phox, PLCβ/(DAG)/PKCδ/p47phox, P-
Rex/Rac, (Hck,Fgr)/Vav/Rac, PI3K/(PIP3)/DOCK-2/Rac. This leads to translocation of PHOX 
components to the plasma membrane and activation of NADPH-oxidase. 
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Table 1. Genomic effects of p66Shc knock out. 
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Figure 1. Peritoneal macrophages from p66Shc-/- mice have reduced PMA inducible superoxide production, trace of 
fluorescence increase. 
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Figure 2. p66Shc-/- macrophages have defect in NAD(P)H oxidase dependent ROS generation. 
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Figure 3. p66Shc-/- macrophages have no significant differences in protein levels of NOX2 subunits with respect to 
macrophages form control mice. 
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Figure 4. p66Shc -/- mice have no difference in blood heme levels from control. 
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Figure 5. p66Shc-/- cells have reduced  phosphorylation of p47phox. 
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Figure 6. p66Shc-/- macrophages have defect in translocation of p47phox to membrane upon PMA induction.  
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Figure 7. Mouse macrophage cell line – RAW 264.7 with siRNA – mediated p66Shc – specific knock down have defect in 
NAD(P)H – oxidase dependent superoxide generation. 
 
 by guest, on Novem
ber 25, 2009
w
w
w
.jbc.org
D
ow
nloaded from
 
  29 
Figure 8. p66Shc(-/-) macrophages do not have a big defect in Rac1/2 activation. 
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Figure 9. p66Shc-/- macrophages have reduced phosphorylation rate of PrkCδ.  
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Figure 10. p66Shc-/- macrophages have reduced activation of Akt and ERK by fMLP 
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Figure 11. Simplified schema of NADPH-oxidase activation 
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